224 related articles for article (PubMed ID: 10503815)
1. Differential kinetics of phenytoin in elderly patients.
Bachmann KA; Belloto RJ
Drugs Aging; 1999 Sep; 15(3):235-50. PubMed ID: 10503815
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
Stephen LJ
Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
[TBL] [Abstract][Full Text] [Related]
3. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
4. Ticlopidine inhibits phenytoin clearance.
Donahue S; Flockhart DA; Abernethy DR
Clin Pharmacol Ther; 1999 Dec; 66(6):563-8. PubMed ID: 10613611
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
Franco V; Perucca E
Expert Opin Drug Metab Toxicol; 2015; 11(8):1269-79. PubMed ID: 26037375
[TBL] [Abstract][Full Text] [Related]
6. Severe phenytoin intoxication in a subject homozygous for CYP2C9*3.
Brandolese R; Scordo MG; Spina E; Gusella M; Padrini R
Clin Pharmacol Ther; 2001 Oct; 70(4):391-4. PubMed ID: 11673755
[TBL] [Abstract][Full Text] [Related]
7. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
Tanaka E
J Clin Pharm Ther; 1999 Apr; 24(2):87-92. PubMed ID: 10380060
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic model analysis of interaction between phenytoin and capecitabine.
Miyazaki S; Satoh H; Ikenishi M; Sakurai M; Ueda M; Kawahara K; Ueda R; Ohtori T; Matsuyama K; Miki A; Hori S; Fukui E; Nakatsuka E; Sawada Y
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):657-65. PubMed ID: 27390048
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.
Fischer TL; Pieper JA; Graff DW; Rodgers JE; Fischer JD; Parnell KJ; Goldstein JA; Greenwood R; Patterson JH
Clin Pharmacol Ther; 2002 Sep; 72(3):238-46. PubMed ID: 12235444
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
DeVane CL; Gill HS
J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
[TBL] [Abstract][Full Text] [Related]
11. Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics.
Iida Y; Nishi S; Asada A
Ther Drug Monit; 2001 Jun; 23(3):192-7. PubMed ID: 11360024
[TBL] [Abstract][Full Text] [Related]
12. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin pharmacokinetics in the elderly.
Kovarik JM; Koelle EU
Drugs Aging; 1999 Sep; 15(3):197-205. PubMed ID: 10503812
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
Iivanainen M
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication.
Ninomiya H; Mamiya K; Matsuo S; Ieiri I; Higuchi S; Tashiro N
Ther Drug Monit; 2000 Apr; 22(2):230-2. PubMed ID: 10774639
[TBL] [Abstract][Full Text] [Related]
16. Overview of the clinical pharmacokinetics of oxcarbazepine.
Flesch G
Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K
Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum phenytoin concentrations associated with coadministration of sertraline.
Haselberger MB; Freedman LS; Tolbert S
J Clin Psychopharmacol; 1997 Apr; 17(2):107-9. PubMed ID: 10950473
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin dosage requirements and pharmacokinetic variables.
Taylor JW; Murphy MJ; Berg MJ; Perry PJ; Lyon LW; Ludden TM
Clin Pharm; 1983; 2(3):253-7. PubMed ID: 6883953
[TBL] [Abstract][Full Text] [Related]
20. Phenytoin age-dose-concentration relationship in children.
Suzuki Y; Mimaki T; Cox S; Koepke J; Hayes J; Walson PD
Ther Drug Monit; 1994 Apr; 16(2):145-50. PubMed ID: 8009561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
